Fluvoxamine to Augment Olfactory Recovery For Long COVID-19 Parosmia
Status:
Not yet recruiting
Trial end date:
2022-05-01
Target enrollment:
Participant gender:
Summary
This study will investigate the efficacy of oral fluvoxamine in olfactory improvement
following Covid-19- associated parosmia. This is a randomized, double-blinded,
placebo-controlled trial.